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Abstract The human proteinase inhibitor, a2-macroglobulin 
(a2-M), inhibits a large number of proteinases. ct2-M-proteinase 
complexes are rapidly cleared from the circulation by binding to 
a cellular receptor (oc2-M-R/LRP) via the receptor binding 
domain (RBD) which is made up of a 20 kDa C-terminal stretch 
of the 180 kDa monomer of the inhibitor. A monoclonal antibody 
(mab a-1) has been described which reacts with the receptor-
recognizable form of the inhibitor, the so called transformed a2-
M (a2-Mf). By screening of a phage display library an epitope in 
the RBD of the inhibitor was identified that reacts with mab a-1. 
Out of 25 phage clones a heptapeptide sequence (S-xi-x2-D-x3-
x4-K) was obtained containing identical amino acids in three 
positions. A consensus peptide (S-R-S-D-P-P-K) was synthesized 
and found to displace a2-Mt from binding to mab a-1 and to 
receptor. The specificity of competition was demonstrated by a 
reversed peptide and a control antibody. By structural compar-
ison it was found that the consensus heptapeptide mimics a 
discontinuous conformationally constrained epitope present in 
the RBD of the inhibitor. This is the first report describing the 
detection of discontinuous epitopes by phage display using a short 
linear peptide. 
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1. Introduction 
Native a2-macroglobulin (a2-Mn) inhibits a large number 
of proteinases of different classes. The complex formation is 
initiated by specific limited proteolysis of the bait region lo-
cated at residues 667-705 of each subunit. The cleavage in-
duces a series of molecular events including the interruption 
of an internal thiolester which triggers conformational 
changes resulting in entrapment of proteases and exposure 
of previously hidden receptor recognition sites (for review, 
see [1]). The protein yielded is the transformed form of a2-
M (a2-Mt). The two different forms can be distinguished by 
surface hydrophobicity, receptor binding activity and mono-
clonal antibodies [2^-]. Treatment of a2-M with methylamine 
leads to thiolester cleavage and results in a transformed mol-
ecule that resembles that of a2-M-proteinase complexes but 
still has an intact but poorly accessible bait region. 
The oc2-Mt binds to the a2-M receptor (a2-M-R) known as 
low density lipoprotein receptor-related protein (a2-M-R/ 
LRP) via the receptor binding domain (RBD) presumably 
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located at the tip of the H-like structure of the inhibitor mol-
ecule [1,5]. The RBD is formed by a 20 kDa C-terminal 
stretch of the 180 kDa monomer [6,7]. 
Recently, we described a monoclonal antibody (mab), a-1, 
reacting with an unknown epitope located at the 20 kDa C-
terminal fragment of a2-Mt. This antibody has been used to 
specifically detect the transformed inhibitor in plasma by ELI-
SA [4]. 
Screening a random phage display library was employed to 
identify an epitope in a2-M reacting with mab a-1. This 
method has been proved to be a powerful technique for de-
tection of peptide ligands for several proteins including mem-
brane proteins, receptors, and antibodies [8-10]. From 25 
phage clones a heptapeptide sequence was deduced which 
may resemble a discontinuous conformationally constrained 
epitope in the RBD of the inhibitor molecule. 
2. Materials and methods 
Peptides were chemically synthesized and purified by HPLC to 95% 
purity by Pepscan GmbH (Berlin, Germany). Monoclonal antibodies, 
purified receptor (a2-M-R/LRP), native tx2-M and methylamine-
treated a2-M (a2-M-MA), also designated oc2-Mt, were purchased 
from BioMac GmbH (Leipzig, Germany). 
Radiolabelling of a2-M-MA with 125I (Amersham, Germany) was 
performed by the chloramine T-method described by Hunter and 
Greenwood [11]. 
Binding experiments were performed by ELISA. Antibodies (2 |ig/ 
ml) or purified receptor (2 ug/ml) were coated to titer plates (Nunc, 
Germany) and were allowed to react with radiolabelled a2-M-MA for 
1 or 3 h at 37°C in the absence or presence of competing ligands at 
increasing concentrations as indicated in the legends of the figures. 
After washing, the bound radiolabelled oc2-M-MA was detected by y-
counting. 
For screening peptide libraries the Phage Display Peptide Library 
Kit, version 1.01 (New England BioLabs) was used. Briefly, mab a-1 
(100 |xg/ml 0.1 M NaHC03, pH 8.6) was coated to a plastic surface. 
For screening, 2X1011 phages containing 2X109 different clones were 
incubated with the immobilized mab. After three rounds of panning, 
plaques were isolated, phages were amplified, and the DNA was iso-
lated. Purity of DNA was checked by electrophoresis. The DNA was 
cycle-sequenced using primers according to the manual. Streptavidin 
was used as control ligand yielding a sequence of His-Pro-Gln as 
described in the manual. 
3. Results 
Heptapeptide epitopes that react with the mab a-1 were 
identified by screening a random phage display library. After 
three cycles of biopanning 25 individual phage clones were 
isolated and their epitope regions were sequenced (Table 1). 
Four different groups of identical clones were found, two 
clones had unique peptide sequences. All peptide sequences 
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Fig. 1. Competition of consensus peptide SRSDPPK and reversed 
peptide KPPDSRS for binding of 125I-<x2-M-MA to immobilized 
mab a-1 and a-11. Titer plates were coated with mab a-1 or mab 
a-11. The wells were incubated with 0.6 nM [125I]a2-M-MA 
(500000 cpm/cavity) and increasing concentrations of consensus 
peptide and r-peptide, respectively, in phosphate buffer (50 mM so-
dium phosphate, 150 mM NaCl, 0.05% Tween 20, pH 7.4) for 1 h 
at 37°C. After washing bound radioactivity was eluted by incuba-
tion with 1 M NaOH/0.7% SDS for 1 h at 37°C. • , consensus pep-
tide and mab a-1; o, consensus peptide and mab a-11; v , r-pep-
tide and mab a-1. The r-peptide which had no competitive effect on 
binding of a2-M to a-11 is not shown in the figure. Inset: Competi-
tion of a2-M-MA for binding of [125I]a2-M-MA to immobilized 
mab a-1 and mab a-11. Conditions were as described above with 
the exception that no peptide but increasing concentrations of a2-
M-MA were applied for competition. • , binding to mab a-1; o, 
binding to mab a-11. 
shared the common motif S-X1-X2-D-X3-X4-K. The most com-
mon amino acids intervening in this motif were R, S, P, P for 
xi, x2, x3, x4, respectively, yielding the consensus sequence of 
R-S-R-D-P-P-K. This consensus peptide was not found 
among the phage sequences. 
A peptide with this sequence was synthesized and its inter-
action with mab a-1 and mab a-11, used as control, was 
evaluated by ELISA. 
Mab a-1, used for biopannmg, recognizes an epitope which 
is only present in a2-Mt, whereas mab a-11 binds to an un-
known epitope common in both the native and the trans-
formed inhibitor. As seen in Fig. 1 the heptapeptide S-R-S-
D-P-P-K competitively inhibited the binding of a2-Mt to mab 
a-1, while binding of a2-Mt to mab a-11 was not affected by 
the peptide. The inhibition constant (IC50) of the heptapeptide 
was estimated to be 300 uM. However, this inhibitory effect is 
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Fig. 2. Effect of consensus peptide and reversed peptide on binding 
to a2-M-R/LRP of [125I]a2-M-MA. Titer plates were coated with 
purified receptor (2 ug/ml). The wells were incubated with 0.6 nM 
[125I]a2-M-MA (500000 cpm/cavity) and increasing concentrations 
of consensus peptide (•) or reversed peptide ( A ) in 20 mM HEPES, 
150 mM NaCl, 5 mM Ca2+, 0.05% Tween 20, pH 7.4 for 3 h at 
37°C. After washing bound radioactivity was eluted by incubation 
with 1 M NaOH/0.7% SDS for 1 h at 37°C. The degree of non-spe-
cific binding to the immobilized receptor evaluated by binding in 
the presence of 20 mM EDTA instead of Ca2+ was subtracted. In-
set: Effect of mab a-1 and mab a-11 on binding of [125I]a2-M-MA 
to immobilized a2-M-R/LRP. Conditions were as described above 
with the exception that increasing concentrations of mab a-1 (•) 
and mab a-11 (a) were used instead of peptides. 
lower than the IC50 of a2-Mt binding to mab a-1 and a-11, 
which were 0.5 nM and 3 nM, respectively (Fig. 1, inset). 
A reversed peptide (r-peptide) with the sequence K-P-P-D-
S-R-S was synthesized to confirm that the sequence obtained 
from the phage library was specifically bound to mab a-1. The 
r-peptide displayed only a weak competitive effect on binding 
of radiolabelled a2-Mt to a-1 and no influence on interaction 
between mab a-11 and the inhibitor was observed (data not 
shown). These findings indicate that the phage-derived peptide 
specifically binds to the antigen binding site in mab a-1, most 
probably by mimicking a certain structural motif in the C-
terminal part of the a2-M polypeptide chain. 
The C-terminal part of the a2-M subunit is known to har-
bor the receptor recognition sites. In a second type of experi-
ments we studied the influence of the consensus peptide on 
binding of a-2Mt to its receptor. First, we tested the effect on 
a2-Mt binding to immobilized a2-M-R/LRP of the mabs a-1 
Table 1 
Epitope sequence of phages isolated after three rounds of biopanning with mab a-1 
1 Ser 
2 Ser 
3 Ser 
4 Ser 
5 Ser 
6 Ser 
Ser 
(25) 
Arg 
Phe 
Thr 
Phe 
Thr 
Arg 
Arg/Thr 
(10/7) 
He 
Ser 
Ser 
Ser 
Leu 
Leu 
Ser/lie 
(14/9) 
Asp 
Asp 
Asp 
Asp 
Asp 
Asp 
Asp 
(25) 
Pro 
Gin 
Pro 
Ala 
Pro 
Pro 
Pro/Gin 
(17/6) 
Pro 
Pro 
Val 
Trp 
He 
Pro 
Pro/Val 
(16/6) 
Lys 
Lys 
Lys 
Lys 
Lys 
Lys 
Lys 
(25) 
(n=9) 
(»=6) 
(n=6) 
(n=2) 
(«=l) 
(n=\) 
The phage epitope was deduced from the DNA sequence. 
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and a-11 (Fig. 2, inset). At low concentrations of mab a-11 an 
increased binding of a2-Mt to oc2-M-R/LRP was observed 
which may be due to an antibody-mediated dimerization of 
the inhibitor but no competition was found at higher antibody 
concentrations. In contrast, mab a-1 caused a clear inhibition 
of receptor binding at concentrations higher than 100 nM. 
The consensus peptide S-R-S-D-P-P-K was found to inhibit 
receptor binding of oc2-Mt, too (Fig. 2). Despite the high 
inhibitory concentration needed (ICgo=4 mM), specificity is 
demonstrated by the absence of inhibition in the case of r-
peptide. 
4. Discussion 
A heptamer peptide library displayed on the N-terminus of 
protein III of bacteriophage M13 was used for epitope map-
ping. Out of 25 clones six different subsets of clones were 
isolated, all containing the common motif S-xi-X2-D-x3-x4-
K. By alignment and calculation of the most frequently occur-
ring amino acids at the intervening positions the consensus 
structure, S-R-S-D-P-P-K, was deduced. Subsequent peptide 
synthesis and inhibition studies clearly demonstrated competi-
tion between radiolabelled a2-Mt and this peptide for binding 
to monoclonal antibody a-1 used for panning. However, the 
competitive effect of the consensus peptide was much less 
pronounced when compared with the whole transformed in-
hibitor. This likely represents suboptimal sequences which 
may be due to the limited size of the library or to the short-
ness of the peptide with missing flanking sequences crucial for 
optimal binding. Recently, it was claimed that antibodies may 
make direct contact with up to 22 amino acid residues of the 
antigen [12]. Thus, a heptapeptide may only comprise most 
essential amino acid residues for binding. Furthermore, a dis-
continuous epitope may be difficult to mimic by a short pep-
tide compared with a continuous epitope. Finally, the consen-
sus sequence which itself is not displayed by the phage may be 
a worse binder than one of the six phage sequences found. 
Fig. 3. Proposed spatial arrangement of discontinuous epitope in 
oc2-M recognized by phage selected from the library. Model of spa-
tial structure of the C-terminal peptide of a2-M. Amino acids are 
symbolized by circles. Single letter code of amino acids is used. A 
disulfide bridge connects Cys-1329 with Cys-1444 (black circles). 
Downstream of C-1329, a loop is formed to bring DEPK and SRS 
close together. Lys(K)-1370 and Lys(K)-1374, which have been 
shown to be crucial for receptor binding, are indicated. For the 
sake of clarity, a loop of a further 62 amino acids is omitted (box). 
h-<x2-M GVQTLPQTCDEPKAHTSFQISLSVSYTGSRSASNMA 
b-a2-M EVQTLPQTCDGPKAHTSFQISLSVSYIGSRPASNMA 
h-PZP KVQTVPQTCDGHKAHTSFQISLTI S Y T G N R P A S N M V 
1357 
h-a2-M IVDVKMVSGFIPLKPTVKMLERSNHVSRTEVSSNH 
b-a2M IVDVKMVSGFIPLKPTVKMLERSN-VSRTEVSNNH 
h-PZP IVDVKMVSGFIPLKPTVKMLERSSSVSRTEVSNNH 
h-a2-M VLIYLDKVSNQTLSLFFTVLQDVPVRDLKPAIVK 
b-a2-M VLI YLDKVSNETLTLF FTVLQDI PVRDLKPAIVK 
h-PZP VLIYVEQVTNQTLSFSFMVLQDIPVGDLKPAIVK 
1426 • 
h-a2-M VYDYYETDEFA IA EYNAPCSKDLGNA 
b-a2M VYDYYETDEFAVAE YNAPCSKDTGNA 
h-PZP VYDYYETDESVVAEY I APCSSDTEHGNY 
Fig. 4. Alignment of amino acid sequence of the receptor binding 
domains of human a2-macroglobulin, human pregnancy zone pro-
tein and bovine a2-macroglobulin. Sequence alignment of the RBDs 
of human a2-M (upper line) [16] with the corresponding domain of 
bovine a2-M (middle line) [17] and with human PZP (lower line) 
[18]. The residues are numbered according to their position in hu-
man a2-M. Bold printed amino acids represent the proposed epit-
ope fragments recognized by phage display. Asterisks indicate Cys 
residues forming the intra-chain disulfide bridge responsible for fold-
ing the C-terminal part of the polypeptide chain. 
However, comparable inhibition constants have been de-
scribed recently when a hexapeptide library was applied [13] 
and somewhat lower constants when a larger (30-mer) peptide 
library was used [12]. Nevertheless, tight binding of phage to 
mab oc-1 sufficient for biopanning was observed, which could 
be attributed to multivalency of binding sites during the pan-
ning process [14,15]. 
Looking for a peptide sequence in the a2-M structure anal-
ogous to the phage-derived consensus peptide we could iden-
tify two peptide stretches which probably represent the com-
mon motif found in the diverse phage-derived peptides, 
namely D-E-P-K (aa 1330-1333) and S-R-S (aa 1349-1351) 
in the C-terminal sequence of the inhibitor. No continuous 
linear sequence was found that coincided with any of the 
phage-derived peptides. Thus, the epitope defined by mab oe-
1 binding may be made up of two different parts in different 
locations within the polypeptide chain and indicates the rec-
ognition of a conformation epitope. This implies that the pol-
ypeptide chain of the C-terminal fragment has to be folded in 
such a way as to bring the two parts of the epitope close 
together. The proposed folded structure is shown in Fig. 3. 
The formed loop is stabilized by a disulfide bond extending 
between Cys-1329 and Cys-1444 [1]. The recent finding that 
mab a-1 does not react with the purified 20 kDa C-terminal 
fragment after reduction and carboxymethylation supports 
our hypothesis [4]. 
Interestingly, the proposed epitope lies in a highly con-
served region of the human inhibitor [16] which shows strong 
homology to related proteins such as bovine oc2-M [17] and 
human pregnancy zone protein (PZP) [18] (Fig. 4). The motif 
D-X3-X4-K is conserved in all three proteins, whereas the motif 
S-X1-X2 is found only in the two macroglobulins but not in 
PZP. This might explain why mab a-1 reacts strongly with the 
bovine inhibitor but not with pregnancy zone protein [4]. The 
nearness of Cys-1329 to the epitope may be the cause of the 
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high sensitivity toward reducing agents of epitope recognition 
by mab oc-1. 
Attempts were made by several authors to identify amino 
acids in the RBD involved in binding of a2-M to its receptor 
by chemical modification experiments and mutational analysis 
[19,20]. Two lysine residues (Lys-1370 and Lys-1374) spaced 
by three amino acids were found to be crucial for receptor 
binding. This is supported by the finding that ovomacroglob-
ulin lacking a lysine residue equivalent to Lys-1374 in ct2-M 
exhibited no affinity to the receptor. However, mutational 
insertion of lysine in this protein did not reconstitute receptor 
binding indicating that in addition to the two lysine residues 
other sites may contribute to receptor binding, too. 
Several discontinuous epitopes have been mapped already 
using the phage display technique. However, either libraries 
comprising larger random peptides were used for that purpose 
[12] or if libraries with smaller peptides were screened, sequen-
ces found after panning could not be assigned to the sequence 
in proteins [13,21], or did not reflect sequences in different 
regions of the protein directly [22]. Our results represent an 
example that different parts of a discontinuous epitope can be 
detected as two linear sequences within one peptide by the 
phage display technique even if libraries comprising short 
random heptapeptides are screened. 
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